China Biologic Products Company Profile (NASDAQ:CBPO)

About China Biologic Products (NASDAQ:CBPO)

China Biologic Products logoChina Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CBPO
  • CUSIP: N/A
  • Web: www.chinabiologic.com
Capitalization:
  • Market Cap: $2.21 billion
  • Outstanding Shares: 27,238,000
Average Prices:
  • 50 Day Moving Avg: $90.93
  • 200 Day Moving Avg: $102.24
  • 52 Week Range: $76.26 - $125.99
P/E:
  • Trailing P/E Ratio: 21.14
  • Foreward P/E Ratio: 14.53
  • P/E Growth: 1.45
Sales & Book Value:
  • Annual Revenue: $344.89 million
  • Price / Sales: 6.41
  • Book Value: $20.26 per share
  • Price / Book: 4.01
Profitability:
  • EBITDA: $155.64 million
  • Net Margins: 31.55%
  • Return on Equity: 21.86%
  • Return on Assets: 18.83%
Debt:
  • Current Ratio: 5.21%
  • Quick Ratio: 3.24%
Misc:
  • Average Volume: 324,763 shs.
  • Beta: 1.75
  • Short Ratio: 6.28
 

Frequently Asked Questions for China Biologic Products (NASDAQ:CBPO)

What is China Biologic Products' stock symbol?

China Biologic Products trades on the NASDAQ under the ticker symbol "CBPO."

How were China Biologic Products' earnings last quarter?

China Biologic Products, Inc. (NASDAQ:CBPO) posted its quarterly earnings results on Wednesday, August, 2nd. The company reported $1.35 EPS for the quarter, beating the Zacks' consensus estimate of $1.30 by $0.05. The business had revenue of $89.28 million for the quarter, compared to analysts' expectations of $97.33 million. China Biologic Products had a return on equity of 21.86% and a net margin of 31.55%. The business's quarterly revenue was down 2.3% on a year-over-year basis. During the same period last year, the firm earned $1.26 earnings per share. View China Biologic Products' Earnings History.

Where is China Biologic Products' stock going? Where will China Biologic Products' stock price be in 2017?

3 equities research analysts have issued 12-month target prices for China Biologic Products' stock. Their forecasts range from $135.00 to $140.00. On average, they expect China Biologic Products' stock price to reach $137.50 in the next year. View Analyst Ratings for China Biologic Products.

Who are some of China Biologic Products' key competitors?

Who are China Biologic Products' key executives?

China Biologic Products' management team includes the folowing people:

  • David Gao, Chairman of the Board, President, Chief Executive Officer
  • Ming Yang CPA, Chief Financial Officer
  • Zhijing Liu, Corporate Vice President
  • Ming Yin, Senior Corporate Vice President
  • Gang Yang, Corporate Vice President, General Manager of Guizhou Taibang
  • David Hui Li, Director
  • Joseph J. Chow, Independent Director
  • Wenfang Liu, Independent Director
  • Yungang Lu, Independent Director
  • Xiaosheng Shao, Independent Director

Who owns China Biologic Products stock?

China Biologic Products' stock is owned by many different of retail and institutional investors. Top institutional investors include Hermes Investment Management Ltd. (2.62%), New Silk Road Investment PTE Ltd. (0.70%) and Strs Ohio (0.03%). Company insiders that own China Biologic Products stock include David Gao, Ming Yang, Ming Yin, Sean Shao, Wenfang Liu, Wp X Biologics Llc, Zhijing Cbpo Liu and Zhijun Tong. View Institutional Ownership Trends for China Biologic Products.

Who bought China Biologic Products stock? Who is buying China Biologic Products stock?

China Biologic Products' stock was bought by a variety of institutional investors in the last quarter, including New Silk Road Investment PTE Ltd., Hermes Investment Management Ltd. and Strs Ohio. View Insider Buying and Selling for China Biologic Products.

How do I buy China Biologic Products stock?

Shares of China Biologic Products can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Biologic Products' stock price today?

One share of China Biologic Products stock can currently be purchased for approximately $81.22.


MarketBeat Community Rating for China Biologic Products (NASDAQ CBPO)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  159 (Vote Outperform)
Underperform Votes:  116 (Vote Underperform)
Total Votes:  275
MarketBeat's community ratings are surveys of what our community members think about China Biologic Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for China Biologic Products (NASDAQ:CBPO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $137.50 (69.29% upside)
Consensus Price Target History for China Biologic Products (NASDAQ:CBPO)
Price Target History for China Biologic Products (NASDAQ:CBPO)
Analysts' Ratings History for China Biologic Products (NASDAQ:CBPO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/4/2017Jefferies Group LLCReiterated RatingBuyLowView Rating Details
5/30/2017Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral -> NeutralMediumView Rating Details
3/3/2017Morgan StanleyReiterated RatingOverweight$135.00N/AView Rating Details
7/5/2016Credit Suisse GroupUpgradeNeutral -> OutperformN/AView Rating Details
1/7/2016Deutsche Bank AGBoost Price TargetBuy$149.00 -> $162.00N/AView Rating Details
(Data available from 10/24/2015 forward)

Earnings

Earnings History for China Biologic Products (NASDAQ:CBPO)
Earnings by Quarter for China Biologic Products (NASDAQ:CBPO)
Earnings History by Quarter for China Biologic Products (NASDAQ CBPO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/20176/30/2017$1.30$1.35$97.33 million$89.28 millionViewListenView Earnings Details
2/23/2017Q416$0.84$0.95$76.61 million$77.60 millionViewN/AView Earnings Details
11/2/2016Q316$1.05$1.22$88.46 million$86.50 millionViewN/AView Earnings Details
8/4/2016Q216$1.16$1.10$87.60 million$91.40 millionViewN/AView Earnings Details
5/4/2016Q116$0.88$0.94$74.00 million$85.60 millionViewN/AView Earnings Details
2/25/2016Q415$0.55$0.74$66.77 million$68.30 millionViewListenView Earnings Details
11/3/2015Q315$0.81$0.82$75.30 million$78.80 millionViewN/AView Earnings Details
8/5/2015Q215$0.87$0.99$71.75 million$79.10 millionViewN/AView Earnings Details
5/6/2015Q1 15$0.84$0.87$70.35 millionViewN/AView Earnings Details
11/5/2014Q4 14$0.43$0.48$63.00 million$68.92 millionViewN/AView Earnings Details
3/12/2014Q413$0.38$0.35$41.50 million$42.60 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.56$47.20 million$53.20 millionViewN/AView Earnings Details
11/8/2012Q312$0.54$41.30 million$53.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for China Biologic Products (NASDAQ:CBPO)
Current Year EPS Consensus Estimate: $4.93 EPS
Next Year EPS Consensus Estimate: $5.59 EPS

Dividends

Dividend History for China Biologic Products (NASDAQ:CBPO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for China Biologic Products (NASDAQ:CBPO)
Insider Ownership Percentage: 2.73%
Institutional Ownership Percentage: 72.82%
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)
Institutional Ownership by Quarter for China Biologic Products (NASDAQ:CBPO)
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2017Zhijing Cbpo LiuInsiderSell7,500$116.49$873,675.00View SEC Filing  
3/2/2017Sean ShaoDirectorSell20,000$100.78$2,015,600.00View SEC Filing  
3/1/2017David GaoCEOSell116,653$100.63$11,738,791.39View SEC Filing  
8/15/2016Ming YangCFOSell21,092$124.32$2,622,157.44View SEC Filing  
8/15/2016Wenfang LiuDirectorSell2,900$124.32$360,528.00View SEC Filing  
8/15/2016Zhijing Cbpo LiuInsiderSell1,968$124.32$244,661.76View SEC Filing  
6/8/2016Wp X Biologics LlcDirectorSell2,775,000$111.00$308,025,000.00View SEC Filing  
5/20/2016Ming YangCFOSell13,908$113.64$1,580,505.12View SEC Filing  
5/20/2016Ming YinVPSell19,618$113.64$2,229,389.52View SEC Filing  
3/11/2016Zhijing Cbpo LiuVPSell282$108.00$30,456.00View SEC Filing  
3/7/2016Wp X Biologics LlcDirectorSell4,257,000$107.00$455,499,000.00View SEC Filing  
12/7/2015Zhijun TongDirectorSell15,000$118.33$1,774,950.00View SEC Filing  
11/4/2015David GaoCEOSell95,991$115.60$11,096,559.60View SEC Filing  
11/2/2015David GaoCEOSell12,891$112.26$1,447,143.66View SEC Filing  
10/29/2015David GaoCEOSell71,118$110.21$7,837,914.78View SEC Filing  
10/26/2015David GaoCEOSell59,542$105.22$6,265,009.24View SEC Filing  
10/20/2015David GaoCEOSell258$105.00$27,090.00View SEC Filing  
10/19/2015David GaoCEOSell200$105.03$21,006.00View SEC Filing  
9/15/2015Ming YangCFOSell9,000$94.56$851,040.00View SEC Filing  
9/15/2015Ming YinVPSell20,508$95.55$1,959,539.40View SEC Filing  
9/14/2015Ming YangCFOSell11,304$97.08$1,097,392.32View SEC Filing  
9/14/2015Wenfang LiuDirectorSell2,717$97.02$263,603.34View SEC Filing  
9/14/2015Zhijing Cbpo LiuVPSell6,786$99.29$673,781.94View SEC Filing  
6/15/2015Wp X Biologics LlcDirectorSell2,645,000$100.28$265,240,600.00View SEC Filing  
11/21/2014Zhijing Cbpo LiuVPSell8,000$68.95$551,600.00View SEC Filing  
11/10/2014Sean ShaoDirectorSell72,500$62.75$4,549,375.00View SEC Filing  
11/10/2014Zhijing Cbpo LiuVPSell7,500$62.75$470,625.00View SEC Filing  
9/15/2014Gang Cbpo YangVPSell2,454$54.00$132,516.00View SEC Filing  
9/15/2014Ming YangCFOSell6,164$54.00$332,856.00View SEC Filing  
9/12/2014Ming YinVPSell3,073$54.00$165,942.00View SEC Filing  
9/12/2013Wenfang LiuDirectorSell2,524$25.00$63,100.00View SEC Filing  
5/14/2013Wp X Biologics LlcDirectorBuy3,112,920$20.00$62,258,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for China Biologic Products (NASDAQ:CBPO)
Latest Headlines for China Biologic Products (NASDAQ:CBPO)
Source:
Loading headlines, please wait.

Social

Chart

China Biologic Products (CBPO) Chart for Tuesday, October, 24, 2017

This page was last updated on 10/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.